Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis
T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan
T. Kimura, T. Morimoto, and Y. Furukawa Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan Cardiovasc Interv Ther 26 2011 234 245
Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings
K. Kolandaivelu, R. Swaminathan, and W.J. Gibson Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher registry
for the j-Cypher Registry Investigators
T. Kimura, T. Morimoto, Y. Nakagawa for the j-Cypher Registry Investigators Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry Circulation 125 2012 584 591
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
G.G. Stefanini, B. Kalesan, and P.W. Serruys Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Lancet 378 2011 1940 1948
Evaluating the 'all-comers' design: A comparison of participants in two 'all-comers' PCI trials with non-participants
S.P. De Boer, M.J. Lenzen, and R.M. Oemrawsingh Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants Eur Heart J 32 2011 2161 2167